| Study |
Reference |
|
Ebrahimi (control unexposed, disease free), 2015
|
Ebrahimi Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study. Mult. Scler. 2015; 21:198-205
|
|
Ebrahimi (control unexposed, sick), 2015
|
Ebrahimi Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study. Mult. Scler. 2015; 21:198-205
|
|
Nguyen (control exposed to IFN), 2019
|
Nguyen Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study. Mult Scler Relat Disord 2019; 28:235-243
|
|
Nguyen (control unexposed, sick), 2019
|
Nguyen Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study. Mult Scler Relat Disord 2019; 28:235-243
|
|
Portaccio (control exposed to IFN), 2018
|
Portaccio Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. Neurology 2018; 90:e823-e831
|
|
Portaccio (control unexposed, sick), 2018
|
Portaccio Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. Neurology 2018; 90:e823-e831
|
